The global molecular modelling market is expected to grow at a CAGR of ~ 15.4% during the forecast period 2017-2023.
Molecular modelling market is a widely used tool in the field of pharmaceutical industries and chemistry for the drug development. It investigate, interpret, explain, and discover new phenomenon of molecules. Molecular modeling is easy to perform with currently available software, but it is difficult get right model and proper interpretation. The major driving factors for the market are increasing investments in R&D, increasing prevalence of chronic diseases, and increasing demand for the better treatment. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality across the world, representing around 60% of all deaths. Changing lifestyle and increasing geriatric population have increased the probability of causing the different diseases. In addition to this, technological advancements, increasing need for the cost-effective treatment and growth in the biology and biosimilars markets have fuelled the market growth. However, high cost of the research and limited availability of skilled professional may affect the growth of the market over the assessment period, negetively.
Sample Report Available at https://www.marketresearchfuture.com/sample_request/4330 .
Some of key players in the market are Fisher Scientific Company LLC. (US), Indigo Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes (France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US), Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics PLC (UK), and Entelos, Inc. (US).
The Americas dominates the global molecular modelling market owing to the presence of huge patient population, high healthcare spending, and increasing government support for research & development. Europe is the second largest global molecular modelling market followed by Asia Pacific. The growth of the European market is majorly attributed to the increasing government support, and high healthcare spending.
Asia Pacific is the fastest growing molecular modelling market. Japan holds the major share of the regional market. Whereas, China and India are the fastest growing market due to rapidly growing economy, increasing healthcare expenditure, and government initiatives for research & development.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Browse complete report at https://www.marketresearchfuture.com/reports/molecular-modelling-market-4330 .
The global molecular modelling market has been segmented on the basis of approach, application, product, and end user.
On the basis of approach, the market is segmented into molecular mechanics approach, and quantum chemistry approach.
On the basis of product, the market is segmented into instruments, reagents, kits, and others.
On the basis of application, the market is segmented into drug development, drug discovery, and other application. Drug discovery is further segmented into direct drug design, indirect drug design, and molecular mimicry. The direct drug design is sub-segmented into lead identification, target identification, and others. Indirect drug design is sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR), and others.
On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, research organizations, and others
The major driving factor for the market are increasing investment of biotechnology and pharmaceutical industries in R&D, increasing prevalence of different diseases, and rising need for the better drug treatments. According to the World Health Organization (WHO), chronic diseases, such as heart disease, respiratory diseases, cancer, stroke, and diabetes are the leading cause of mortality across the globe, which represents about 60% of all deaths. Additionally, 80% of the chronic disease deaths occur in low and middle income countries. Moreover, technological advancements, growth in the biology and biosimilars markets, increasing need for the cost effective treatment, and increasing government support for research & development expected to fuel the market growth during the forecast period. However, high cost of the research & development may hamper the market growth during the corresponding period.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –